Pharma Research
- All
- News
- Videos
-
Pharma Research To Get Boost As Government Eases Licence Norms
In a move to fast-track drug research, the Union Health Ministry is set to amend the New Drugs and Clinical Trials (NDCT) Rules, 2019, that will halve licence applications and reduce approval timelines.
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
Centre Approves Rs 700 Crore To Set Up Institutes Of Pharma, Medical Technology
The Central government has earmarked Rs 700 crore to set up centres of excellence at the National Institutes of Pharmaceutical, Education & Research (NIPER) over the next five years to boost pharma and medical technology in the country.
-
Clinical Research Firm for Nykaa, FirstCry Partners Qila.io to Receive Blockchain Revamp
Clinical research centre Mascot Spincontrol and blockchain firm Qila has collaborated to keep the integrity of medical research work intact with secure and tamper-proof data storage. Blockchain technology prevents the concentration of data in one location, making it difficult for hackers or other malicious agents to manipulate the stored informatio...
-
IIT Kanpur Professor Wins Sun Pharma Science Foundation Research Award
Dr Ateeq is a recipient of the Shanti Swarup Bhatnagar Prize in Medical Sciences (2020). She is also an Elected Fellow of the National Academy of Sciences, India (NASI) and the Indian Academy of Sciences, Bangalore (IASc).
-
Parliament Passes Bill To Enhance Status Of Six More Institutes Of Pharma Education, Research
The Bill has come with four amendments which includes qualifying six NIPERs as institutes of national importance and introducing undergraduate and diploma courses, Health Minister Mansukh Mandaviya said
-
BDR Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG In India
BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.
-
Mankind Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG
Drug firm Mankind Pharma today said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
CSIR Collaborates With Aurobindo Pharma To Develop COVID-19 Vaccines
The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited on Tuesday announced a collaboration to develop vaccines for COVID-19.
-
Allocate More Funds, Increase Expenditure, Say Health Experts
Health experts have pitched for more fund allocation in sectors such as family planning and non-communicable diseases.
-
Medical Technology Association Wants Tax Holidays For Research Centres
"We also demand tax incentives for the industry for developing global patents from India," said MTaI.
-
Indian Pharma Tycoons Foray Into New Drugs To Shore Up Growth
Indian drugmakers are embarking on a research spending spree to master more complex therapies and their billionaire founders look willing to absorb the costs.
-
'Withdrawl of Tax Exemption to Negatively Impact Innovation'
Withdrawal of tax exemption for research and development is likely to negatively impact India's innovation efforts, pharma major Dr Reddy's Laboratories said today.
-
US Panel: More Research Needed to Justify Universal Autism Screening
An influential US health panel said on Monday it needs more evidence to support universal screening for autism in young children who show no developmental problems, in a departure from recommendations issued by other medical groups.
-
Pharma Research To Get Boost As Government Eases Licence Norms
In a move to fast-track drug research, the Union Health Ministry is set to amend the New Drugs and Clinical Trials (NDCT) Rules, 2019, that will halve licence applications and reduce approval timelines.
-
Pharma, Semi-conductors, Energy Products Exempted From Trump's Tariff
Essential and strategic items such as pharmaceuticals, semiconductors, copper, and energy products like oil, gas, coal and LNG are exempted from the 26 per cent import duty announced by the US on Wednesday, according to think tank GTRI.
-
Centre Approves Rs 700 Crore To Set Up Institutes Of Pharma, Medical Technology
The Central government has earmarked Rs 700 crore to set up centres of excellence at the National Institutes of Pharmaceutical, Education & Research (NIPER) over the next five years to boost pharma and medical technology in the country.
-
Clinical Research Firm for Nykaa, FirstCry Partners Qila.io to Receive Blockchain Revamp
Clinical research centre Mascot Spincontrol and blockchain firm Qila has collaborated to keep the integrity of medical research work intact with secure and tamper-proof data storage. Blockchain technology prevents the concentration of data in one location, making it difficult for hackers or other malicious agents to manipulate the stored informatio...
-
IIT Kanpur Professor Wins Sun Pharma Science Foundation Research Award
Dr Ateeq is a recipient of the Shanti Swarup Bhatnagar Prize in Medical Sciences (2020). She is also an Elected Fellow of the National Academy of Sciences, India (NASI) and the Indian Academy of Sciences, Bangalore (IASc).
-
Parliament Passes Bill To Enhance Status Of Six More Institutes Of Pharma Education, Research
The Bill has come with four amendments which includes qualifying six NIPERs as institutes of national importance and introducing undergraduate and diploma courses, Health Minister Mansukh Mandaviya said
-
BDR Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG In India
BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.
-
Mankind Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG
Drug firm Mankind Pharma today said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
CSIR Collaborates With Aurobindo Pharma To Develop COVID-19 Vaccines
The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited on Tuesday announced a collaboration to develop vaccines for COVID-19.
-
Allocate More Funds, Increase Expenditure, Say Health Experts
Health experts have pitched for more fund allocation in sectors such as family planning and non-communicable diseases.
-
Medical Technology Association Wants Tax Holidays For Research Centres
"We also demand tax incentives for the industry for developing global patents from India," said MTaI.
-
Indian Pharma Tycoons Foray Into New Drugs To Shore Up Growth
Indian drugmakers are embarking on a research spending spree to master more complex therapies and their billionaire founders look willing to absorb the costs.
-
'Withdrawl of Tax Exemption to Negatively Impact Innovation'
Withdrawal of tax exemption for research and development is likely to negatively impact India's innovation efforts, pharma major Dr Reddy's Laboratories said today.
-
US Panel: More Research Needed to Justify Universal Autism Screening
An influential US health panel said on Monday it needs more evidence to support universal screening for autism in young children who show no developmental problems, in a departure from recommendations issued by other medical groups.
